IRBM and Sanofi publish in J. Med. Chem. on optimizing the Relaxin-2 peptide hormone in cardiovascular disease
Peptid-Synthese im Liberty Blue The insulin-like peptide human relaxin-2 was identified as a hormone that, among other biological functions, mediates the hemodynamic changes occurring during pregnancy. Recombinant relaxin-2 (serelaxin) has shown beneficial effects in acute heart failure, but its full therapeutic potential has been hampered by its short half-life and the need for intravenous administration […]